Several hours after admission, he states that he is experiencing palpitations and an ECG is obtained. The initial part of the ...
Smartwatches may play a key role in spotting heart rhythm problems. A study by Amsterdam UMC, in partnership with Cardiologie ...
This week, Bobbi Conner talks with Dr. Rachel Kaplan about managing atrial fibrillation. Dr. Kaplan is an Associate Professor ...
Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...
A Dutch trial evaluated 6 months of Afib screening in a high-risk, older population using Apple Watches, which have both photoplethysmography and electrocardiography functionality. The intervention ...
A study in the journal Heart shows brisk walking can cut the risk of atrial fibrillation by up to 43%. We spoke to a ...
The Atrial Fibrillation (AFib) market is currently undergoing substantial expansion, fueled by several converging factors ...
Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...
In North Carolina, a state that had legislated its commitment to life, Ciji Graham spent her final days struggling to find ...
Abbott Park, Illinois Thursday, January 22, 2026, 09:00 Hrs [IST] ...
Clinical Trials Arena on MSN
Kardium unveils further pivotal trial results for Globe PFA system
Globe is claimed to be the only PFA system that enables single-shot PVI and targeted ablation using a single catheter.
Abbott's fourth quarter revenue missed expectations in its devices, diagnostics and nutrition segments, while staying in line for its established pharmaceutical business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results